Open Access

Novel direct thrombin inhibitor achieves superior antithrombotic effect with lower bleeding risk than heparin or bivalirudin

Congress Session

About the speaker

Assistant Professor Cho Yeow Koh

National University of Singapore, Singapore (Singapore)
0 follower

3 more presentations in this session

State of the Art - Novel targets in anti thrombotic drug development

Speaker: Associate Professor B. Rocca (Rome, IT)

Thumbnail

Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients

Speaker: Professor R. Storey (Sheffield, GB)

Thumbnail

Evaluation of the pharmacodynamics of a ticagrelor reversal agent PB2452

Speaker: Professor L. Jennings (Memphis, US)

Thumbnail

Access the full session

New developments in anti thrombotic drug therapy

Speakers: Assistant Professor C. Koh, Associate Professor B. Rocca, Professor R. Storey, Professor L. Jennings
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk